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Reactive oxygen species (ROS) are essential for cellular signalling and 
physiological function. An imbalance between ROS production and 
antioxidant protection results in a state of oxidative stress (OS), which is 
associated with perturbations in redox regulation, cellular dysfunction, organ 
failure and disease. The pathophysiology of OS is closely interlinked with 
inflammation, mitochondrial dysfunction and, in the case of surgery, 
ischemia/reperfusion injury. Perioperative OS is a complex response that 
involves patient, surgical and anaesthetic factors. The magnitude of tissue 
injury inflicted by the surgery affects the degree of OS, and both duration and 
nature of the anaesthetic procedure applied can modify this. Moreover, the 
inter-individual susceptibility to the impact of OS is likely to be highly variable 
and potentially linked to underlying comorbidities. The pathological link 
between OS and postoperative complications remains unclear, in part due to 
the complexities of measuring ROS and OS-mediated damage. Exogenous 
antioxidant use and exercise have been shown to modulate OS and may have 
potential as counter-measures to improve postoperative recovery. A better 
understanding of the underlying mechanisms of OS, redox signalling and 
regulation can provide an opportunity for patient-specific phenotyping and 
development of targeted interventions to reduce the disruption that surgery 
can cause to our physiology. Anesthesiologists are in a unique position to 
deliver countermeasures to OS and improve physiological resilience. To shy 
away from a process so fundamental to the welfare of these patients would be 
foolhardy and negligent, thus calling for an improved understanding of this 
complex facet of human biology. 




GLOSSARY OF TERMS AND ABBREVIATIONS 
.NO – Nitric oxide 
.OH - Hydroxyl radical 
8-OHdg - 8-hydroxy-2’-deoyguanosine 
AAA – Abdominal aortic aneurysm 
BAL- Bronchial alveolar lavage 
BAP - Biological antioxidant potential 
CABG – Coronary artery bypass graft 
CAT- Catalase 
CVD- Cardiovascular disease 
DAMPs - Damage associated molecular patterns 
ETC – Electron transport chain 
GA – General anaesthesia 
GPx – Glutathione peroxidase 
GSH - Reduced glutathione 
GSSG-Glutathione disulfide 
H2O2  - Hydrogen peroxide 
HNE – 4-Hydroxynonenal 
IMM – Ineer mitochondrial membrane 
IP – Ischemia perfusion 
IR – Ischemia reperfusion 
IRI - Ischemia reperfusion injury 
MDA - Malonaldehyde 
MPO - Myeloperoxidase 
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mtDNA – Mitochondrial DNA 
N2O – Nitrous oxide 
NF-κB - Nuclear factor-κB 
NLR-NOD like receptors 
NLRP3 - Leucine Rich Repeat And Pyrin-Domain Containing-3  
NOD - Nucleotide-binding oligomerizations domain 
NOX – NADPH oxidase 
O2·- - Superoxide 
OLV – One lung ventilation 
ONOO- - Peroxynitrite 
ORP – Overall redox potential 
OS - Oxidative stress 
OXPHOS - Oxidative phosphorylation 
POC – Point of care 
PPAR-γ- Peroxisome proliferator activated receptor-γ 
RA – Regional anesthesia 
ROS - Reactive oxygen species 
RNS – Reactive nitrogen species 
RSS – Reactive sulfur species 
SOD – Superoxide dismutase 
TIVA – Total intravenous anethesia 
TLR – Toll like receptors 
TNF – Tumour necrosis factor 
WHO – World Health Organisation




Life evolved in an environment devoid of oxygen, and it was not until the 
appearance of photosynthesis that oxygen began to accumulate in the Earth’s 
atmosphere, radically altering the trajectory of evolution.1 The key inflection 
point in the story of life on Earth was the joining of two ancient single-celled 
organisms (a small obligate aerobe and a larger anaerobe) to create what 
became the forerunner of the eukaryotic cell. The aerobic bacteria had 
evolved a process to use oxygen as an electron acceptor and unlock energy 
from carbon compounds. They were the ancestors of the mitochondria, and 
the energetic process was oxidative phosphorylation (OXPHOS). The 
advantage of this biological union for the anaerobic bacteria was protection 
from the rising concentration of oxygen in the Earth’s atmosphere 2.5 billion 
years ago. In exchange, the recipient cell and every one of its descendants 
gained an in-house, oxygen-fired power plant. Oxygen is a relative reactive 
molecule, which makes it a high-risk choice for an electron acceptor in an 
energetic pathway. It also explains the paradox that although it is essential for 
aerobic life, excess oxygen can have devastating effects on the framework 
and function of cells, through the generation of reactive oxygen species 
(ROS) that are produced in cellular metabolism and OXPHOS. 
Reduction/oxidation (redox) reactions are fundamental to biochemical 
reactions driving the cellular machinery. Cells must keep ROS production 
under control to maintain harmony, and disruption of the fine balance between 
formation, scavenging and safe deposition can create a state of oxidative 
stress (OS). We cannot live without oxygen, too much can harm us.  
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While this may seem a million miles away from the setting of an operating 
room, anesthesiologists have a duty to optimise patients in long-term health 
and well-being. Arguably, this role includes minimising exposure to OS in a 
similar way to which we now try to avoid an excessive perioperative 
inflammatory response. Preoperatively OS has been implicated in the 
pathogenesis of multiple disease entities2, intraoperatively OS underlie the 
mechanism of the acute phase response during injury and stress3, and 
postoperatively measures of OS have been correlated to complications after 
surgery4, which may have potential to becoming risk stratifying biomarkers. 
We often assume what we cannot see will not harm us; however, with OS this 
is clearly not the case. Multiple avenues are being explored to understand and 
reduce perioperative OS, in order to prevent harm from this silent enemy.  
 
REACTIVE OXYGEN SPECIES, REDOX REGULATION AND OXIDATIVE 
STRESS  
In humans, ATP is primarily derived from the OXPHOS process taking place 
in the inner mitochondrial membrane (IMM). Oxygen, delivered to our cells 
through a combination of convective and diffusive processes, acts as an 
electron acceptor in a series of reduction/oxidation (redox) reactions that 
occur across five sophisticated protein structures (named complex I to 
complex V) in the electron transport chain (ETC). Energy released during the 
flow of electrons through these complexes is used to move protons against an 
electrochemical gradient across the IMM. The ensuing build-up of potential 
energy (in the form of a pH and electrochemical gradient) is then used to 
create ATP as protons flow back across the membrane via ATP synthase.5 At 
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complexes I and III a small proportion of electrons are uncoupled from the 
ETC and oxygen is reduced to superoxide anions (O2·-).6 The addition of an 
unpaired electron to oxygen makes this intermediate highly reactive; 
subsequent additions of electrons give rise to hydrogen peroxide (H2O2) and 
then to the hydroxyl radical (×OH), other members of the ROS family 
(information box 1). The production of these ROS is part of normal cellular 
biology and oxidative metabolism. Several other cellular sites have been 
identified as centres of ROS production, residing in redox systems of 
enzymes within cellular organelles and the cytosol; in general, they are 
classified into mitochondrial and extra-mitochondrial sources (Figure 1).7 
Some of the key redox enzymes involved are summarised in Figure 2. At 
physiological concentrations, ROS serve numerous essential roles in cell 
signalling, immunity, differentiation and apoptosis.8 Cell and tissues have a 
multi-layered innate defence system against excessive build-up of ROS, 
primarily in the form of ROS-metabolising enzymes, including superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and small-
molecule antioxidants.9 Many non-enzymatic antioxidants are dietary in 
nature, and include a-tocopherol, ascorbic acid (vitamins E and C), and ß-
carotene, whereas the lipophilic co-enzyme Q10 (ubiquinol), which plays an 
important role in the mitochondrial electron transport chain (ECT), is also 
produced endogenously.10,11 Redox reactions are present in almost all 
aspects of life, redox regulation and signalling balances the body’s internal 
state of pro-oxidant and antioxidant reactions. Physiological levels of ROS are 
normally kept in check by these homeostatic processes, but disturbances can 
lead to increased peak concentrations of ROS and a state of pathological 
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OS.9 This has multiple consequences: it can result in oxidative modification 
and degradation of nucleic acids, proteins, and lipids,2 compromising the 
infrastructure of life itself. Lipid peroxidation products play a key role in this 
setting due to their self-perpetuating chain reactivity,12 with mitochondria 
proposed to be at the centre of their generation while simultaneously being 
the targets that lead to interference in their metabolism.13,14 Concomitantly, 
their reaction with protein thiols modifies the way cells adapt to stress.15 OS 
can change the way different cells and cellular organelles communicate with 
each other, perturbing the flow of communication within and between cells 
and organs via an interconnected redox system.16 In an analogy to our 
genetic code there exists a ‘redox code’, a set of principles according to which 
redox changes throughout the body are organised.17 Furthermore, a family of 
N-based molecules called reactive nitrogen species (RNS) exist, which 
originate from the activity of nitric oxide synthase (NOS). Its most prominent 
member is peroxynitrite (ONOO-), a potent pro-oxidant derived from the 
reaction of nitric oxide (×NO) with superoxide, which is formed particularly 
under inflammatory conditions.18 Both ROS and RNS can target cysteine 
thiols leading to a variety of oxidative changes, which can affect thiol-based 
signalling and the function of numerous membrane proteins and cytosolic 
enzymes. In addition, various reactive sulfur species (RSS) exist,19 with both 
pro-oxidant and antioxidant effects some of which are closely linked to 
mitochondrial function.20 The interactions of ROS, RNS, RSS and their 
downstream biological targets are not fully understood, and a novel concept of 
the ‘reactive species interactome’ has been formulated to further elucidate the 
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mechanistic relationships.21 For the purpose of this review, however, we shall 
concentrate on the effects of ROS and their contributions to OS.  
 
SURGERY AND OXIDATIVE STRESS 
Surgery is an acute event that not only results in localised tissue injury but 
also systemic dysfunction. Inflammation and ischemia/reperfusion (IR) injury 
are two important components in this process, and ROS play a role in their 
modulation.22 Surgery classically results in a ‘stress response’ driven by 
endocrine changes that lead to metabolic sequelae.23 Cytokines play a key 
role, driving the ebb and flow of the inflammatory response.24 What is less 
well described is the close interplay this stress response has with OS, which 
directly links mitochondrial function to the effects of surgery. ROS produced 
by mitochondria have been shown to enhance inflammatory processes 
through the activation of cellular receptors, transcription factors and the 
formation of the inflammasome, via the release of mitochondrially mediated 
damage associated molecular patterns (DAMPs) (Figure 3).25  
IR injury (IRI) is classically associated with organ transplantation, cardiac, and 
hepatic surgery, along with the use of limb tourniquets and vascular clamps. 
During the ischemic phase of IRI, anaerobic respiration prevails, leading to a 
state of acidosis and ATP depletion; this is accompanied by the accumulation 
of reduced cofactors in the mitochondrial ETC. The reduced availability of 
energy limits ion pump function in cell membranes, causes calcium overload, 
eventually cell death. Extracellular ATP release26 in conjunction with the 
release of pro-inflammatory markers, sets a stage for an oxidative burst 
during the reperfusion phase, when paradoxically the re-introduction of 
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oxygen causes the release of ROS, OS and further tissue damage.27 The 
common enzymatic sources include xanthine oxidase (XO), NADPH oxidase 
(NOX), the mitochondrial ECT and uncoupled NOS.28 Reperfusion is a highly 
dynamic response, and the accompanying injury can continue for days. The 
presence of ROS in the latter part of the recovery phase serves opposite roles 
to the acute phase, functioning as essential signalling molecules in post-
reperfusion healing, through the stimulation of angiogenesis and tissue re-
modelling.27 The relationship between ROS, oxygen homeostasis and 
mitochondrial dysfunction is central to the pathological mechanism of 
perioperative OS. In addition, sustained OS also contributes to the 
development of a number of chronic diseases and frailty;29 comorbidities that 
contribute to increased perioperative risk.  
 
MEASURING OXIDATIVE STRESS 
The detection and quantification of ROS in biological systems is challenging, 
due to their short-lived and highly reactive nature,30 but also to the 
involvement of multiple cells/tissues in the whole-body, and their responses to 
injury. Electron paramagnetic resonance is considered the gold standard for 
ROS detection and the only technique that offers direct measurement of 
unpaired electrons, but signal detection is complex. Multiple alternative 
techniques have been developed to measure products of ROS-mediated 
damage. Analytical methods for quantification of these reaction products 
include immunoassays, liquid chromatography and mass spectrometry.31,32 
Stable end products of ROS damage to membrane lipids, cellular proteins and 
nuclear constituents include the lipid oxidation products malondialdehyde 
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(MDA), 4-hydroxynonenal (HNE) and F2-isoprostanes (8-iso-prostaglandin-
F2a); 8-hydroxy-2’-deoyguanosine (8-OHdg) and protein carbonyls, oxidation 
products of DNA and amino acid residues, respectively. Measuring 
endogenous antioxidant enzymes such as GPx, CAT and SOD as well as the 
change in the ratio of reduced/oxidized thiol (e.g. glutathione and cysteine) 
concentrations can also provide information about the overall oxidative 
burden, but there is no agreement on which marker is more useful and under 
what condition. Perhaps the greatest challenge to the interpretation of any of 
these readouts is their biological inter-connectedness and our limited 
understanding about redox regulation at the whole-body level.21 Novel 
technologies are available that use a composite electrochemical readout of 
the overall redox potential (ORP), derivatives of reactive oxygen metabolites 
(dROMS) or biological antioxidant potential (BAP). Point of care (POC) 
systems now exists to provide rapid readings of OS from a small amount of 
blood. A growing body of work explores the application of these as a 
prognostic marker of disease progression and severity.33–36  Since laboratory 
tests are expensive, lengthy and complicated techniques, the validation of 
POC measurements could bring the science of OS to the bedside. 
 
PREOPERATIVE THERAPEUTIC STRATEGIES TO REDUCE OXIDATIVE 
STRESS 
Oxidative stress in ageing and obesity 
Ageing and obesity have a significant impact on global health,37,38 which form 
a cohort high risk patient undergoing surgery. Whilst ageing is unavoidable, 
some of its biological consequences may be averted. The trajectory at which 
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this occurs differs between individuals, and it is not the risk of ageing per se 
but the phenotypic expression of frailty that render patients at higher risk of 
perioperative complications.39 Much still remains to be learnt from the 
underlying processes which drive ageing, it has been postulated that 
biological imperfectness, leading to cumulative damage over time, causes the 
overarching effect of this.40 Harman’s free radical theory of ageing41 forms an 
important piece of this puzzle, and a progressive weakening of our innate 
antioxidant system contributes to this.42 One theory suggests the overlapping 
signalling pathways and positive feedback loops between OS and 
inflammation lead to a state of chronic inflammation (‘inflammageing’).43 This 
renders cells more susceptible to injury, catabolism and age-related 
diseases,3,44 involving progressive loss of muscle strength (sarcopenia) and 
increase in adiposity.45 Obesity compounds the ageing process in some 
people and, in conjunction with metabolic syndrome, is another hotbed of 
OS.46 Excessive deposition of adipose tissue acts as an endocrine organ, 
secreting cytokines and hormones, collectively termed adipokines. These 
adipokines trigger the release and activation of the innate immune systems, 
resulting in a state of increased inflammation and OS.47 In addition, obese 
individuals are further prone to higher OS due to their lower antioxidant 
capacity, with demonstrated lower levels of SOD, CAT, and GPx as well as 
vitamins A, E and C concentrations.48,49 Excessive fat accumulation also 
impairs glucose metabolism, and increases mitochondrial and peroxisomal 
oxidation, resulting in a vicious cycle of ROS production and cytokine 
release.50 
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Perioperative antioxidant use 
Therapeutic strategies to reduce perioperative OS have the potential to 
improve clinical outcomes. Antioxidants prevent the transfer of electrons to 
and from molecular oxygen and organic molecules, accelerate ROS 
elimination and promote termination of ROS related reactions.51 The 
evidence, however, for antioxidant use in chronic diseases has been 
conflicting.52,53 In cancer, for example the most convincing evidence from 
epidemiological studies in the reduction of the incidence of carcinogenesis, 
have been from a diet rich in fruit and vegetables,54,55 rather than the use of 
vitamin supplementation alone.  
In the perioperative arena, vitamin C and N-acetylcysteine have shown some 
promising results post cardiac surgery; the use of vitamin C reduced 
postoperative atrial fibrillation 56 and N-acetylcysteine reduced the incidence 
of atrial fibrillation and acute kidney injury.57 The therapeutic benefits of 
antioxidants in non-cardiac surgery remain uncertain and have generated 
discordant results,32  a systematic review of the present literature in 
perioperative use of antioxidants in non-cardiac surgery is underway.58 
Several promising agents are currently being investigated; some with intrinsic 
antioxidant capacities, such as curcumin and cannabidiol, others with 
pleiotropic effects in OS modulation, such as statins59 and telmisartan.60 To 
protect from IRI, anti-diabetics such as metformin can lead to a reduction in 
ROS formation during the reperfusion phase by inhibiting mitochondrial 
complex I.61 Pioglitazone, a peroxisome proliferator activated receptor-γ 
(PPAR-γ) agonist (a nuclear receptor that interacts with multiple survivor 
genes) has been shown to regulate proteins involved in the tolerance to IRI.62 
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Resveratrol, a naturally occurring compound found in many plants including 
grapes, has pharmacological effects mimicking calorie restriction, exerting 
anti-inflammation and anti-OS properties.63 Early work in animal models of 
sepsis have demonstrated ROS reduction and modulation of inflammation.64 
Melatonin could also potentially prove to be a strong candidate; it is an 
ancient molecule that has not altered in billions of years,65 that is present in 
almost every organism on Earth66 and has functionally diverse effects 
including anxiolysis, pain relief, delirium prevention, anti-inflammation and 
anti-oxidation.67–69  
In this developing and complex field of redox medicine, it is important to 
highlight that the notion of perioperative antioxidant administration to 
ubiquitously reduce OS and improve outcomes is almost certainly over-
simplistic. A more stratified approach involving multiple biomarkers and 
individual phenotyping may be required.70 One tablet is highly unlikely to 
provide uniform benefit to every patient undergoing all types of surgery - a 
targeted approach focussing on the detection of OS-induced deficiencies, 
followed by supplementation tailored to individual patients could be an 
alternative approach. 
 
Exercise: the panacea? 
The WHO has identified physical inactivity as the 4th leading risk for global 
mortality, closely followed by obesity in 5th position.71 The health benefits of 
regular exercise are widely accepted, particularly in obesity; exercise assists 
weight loss, reduces body fat percentage and increases lean body mass.72 
This has associated benefits in reducing metabolic disease, cardiovascular 
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disease (CVD) and cancer.73 However, ‘fitness’ per se may not necessarily be 
the key factor in this equation, it could simply be a surrogate measure of what 
is happening at the cellular level. Studies over the past 30 years have 
concentrated on the effects of ROS on skeletal and cardiac muscle.74 ROS 
are released during exercise in a dose-dependent manner and directly 
interlinked to exercise-induced muscular modifications (fitness). The increase 
in oxygen demand must be matched by oxygen delivery and mitochondrial 
activity, and the latter is thought to drive the increased ROS production. Whilst 
the acute OS is likely to inflict some molecular damage, this is thought to be 
accompanied by an adaptive antioxidant response.75 The balance of ROS 
release versus antioxidant response lies in the intensity and duration of 
exercise. The concept of hormesis, referring to a sub-lethal dose of toxin that 
can increase the tolerance of the organism to withstand higher doses of 
toxins, can be applied to exercise in this respect.76 Acute strenuous activity 
has been linked to higher ROS release and a state of OS; however, 
moderate, sustained exercise conditioning induces the endogenous 
antioxidative system and provides protection against OS.77 Studies on 
endurance exercise training and cardiac myocytes have demonstrated a 
phenotype which is resistant to IRI.78 The induction of mitochondrial SOD in 
cardiac myocytes was required to achieve optimal cardio-protection.79 Similar 
findings have been reflected in the skeletal muscle of individuals undergoing 
exercise training, they tend to have higher levels of antioxidants in their 
muscle.80 Yet, supplementation with exogenous antioxidants during exercise 
training has yielded mixed results. Antioxidants may abrogate the health 
benefits of exercise training via interference with exercise-induced signaling 
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pathways.81,82 Exercise and antioxidant use in the ageing population, 
however, have indicated more promising results.83 
The answer may fundamentally lie between the link between regular exercise 
and longevity.41,84 There is mounting evidence that physical training and 
exercise combats the effects of ageing and reduces the effects of age-related 
diseases.45 The effects of ageing and chronic illness can have deleterious 
effects in skeletal muscle functioning. Sarcopenia has been associated with 
chronic exposure to OS, inflammation and the reduction in antioxidant 
capacity as a result of aberrant cellular signalling.75,85 Yet in contrast, elderly 
physically active individuals show antioxidant activity and lipid peroxidation 
levels similar to young sedentary subjects, emphasising the importance of 
regular physical activity to decelerate the age-associated impairment process. 
In perioperative medicine, prehabilitation has a growing body of work 
investigating the beneficial effects of exercise programmes prior to elective 
surgery.86 Exercise in many instances have been shown to be more effective 
than costly pharmacological interventions.87 This universal benefit aligns with 
the concept of exercise ‘training’ our cellular antioxidant systems; through 
mapping of the biological pathways involved, in order to prescribe 
individualised exercise programmes prior to surgery.  
 
INTRAOPERATIVE OXIDATIVE DAMAGE LIMITATION: CAN ANYTHING 
BE DONE? 
The effects of surgery 
The intraoperative OS response to surgical intervention is heavily influenced 
by the magnitude of the surgery, the technique used, and the sequelae of 
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inflammation and IRI experienced. Many studies have demonstrated 
increased OS levels following more invasive techniques compared to their 
minimally invasive counterparts. Demonstrated in open versus endovascular 
abdominal aortic aneurysm (AAA) repair 88, open versus laparoscopic 
abdominal surgeries,89 and on-pump versus off-pump cardiopulmonary by-
pass grafting (CABG).90,91 There are some clinical associations linking 
postoperative recovery with levels of OS, however, the evidence base 
remains in its infancy. The length of IR in particular appears to be an 
important factor in the degree of OS. In a study of 132 patients who 
underwent one lung ventilation (OLV), the duration of OLV correlated with the 
degree of OS detected.92 These effects can also be seen in orthopaedic 
surgery. The use of a tourniquet to provide a bloodless field has been 
associated with subsequent ROS release,93 which correlated with localised 
tissue damage, delayed wound healing, and other postoperative 
complications relating to operative limb ischemia.94  
An emerging theme arises from these studies, that is the wide range of small 
randomised controlled or observational trials using different OS markers 
collected from a variety of body fluids or tissues obtained from subjects, thus 
making overall evaluation challenging.  
It should also be noted that not all forms of IR have deleterious effects on 
health. Indeed, some of the benefits have been harnessed in a technique 
known as ischemic preconditioning (IP). When multiple brief ischemic 
episodes to the coronary artery were delivered prior to a sustained occlusion 
in animal models, the infarct size was smaller in the preconditioned group 
compared to controls,95 demonstrating that a brief period of ischemia protects 
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an organ or tissue from subsequent more prolonged ischemia. Interestingly, 
the potential benefit from this phenomenon is not limited to the organ in 
question, there are systemic effects and this is referred to as remote IP. 
Commonly a limb receives a brief period of ischemia, in order to provide 
protection to distant vital organs.96 Its clinical value has been explored in 
cardiac 97 and transplantation surgery98 and it has been shown to reduce 
systemic OS in animal models of cardiac bypass99 and cardiac arrest.100. 
The effects of anaesthesia 
General anaesthesia 
The modern anesthesiologist has a wide range of pharmaceutical agents at 
their disposal, however, virtually nothing is taught about their properties in 
relation to OS. The intravenous anaesthetic agent propofol has a phenolic 
structure similar to that of vitamin E, possibly accounting for its antioxidant 
properties.101 In vitro and animal studies have demonstrated propofol to be a 
peroxynitrite scavenger, activator of heme oxygenase-1 and modulator protein 
kinase activity.102,103 Conversely, ketamine has been shown to cause 
mitochondrial dysfunction and an increase in regional and global OS levels in 
the brain and liver.104–106 The volatile anaesthetics are halogenated ethers 
and like propofol, they have also been shown to have properties that reduce 
OS. Most of our knowledge regarding this is from animal and cellular models 
where the use of isoflurane and sevoflurane have demonstrated antioxidant, 
anti-apoptotic and anti-inflammatory effects.107,108 In particular, these two 
volatile agents have cardio-protective effects and, when used to precondition, 
can prevent damage from ischemia.108,109 Associated renal and cerebral 
protective effects have also been demonstrated.110 The antioxidant effect of 
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total intravenous anesthesia (TIVA) has been compared to inhaled volatile 
anaesthetics in a small number of clinical studies. The decrease in OS 
markers with or without an increase in antioxidant capacity has been recorded 
in orthopaedic, thoracic, general surgical and hepatic surgeries where TIVA 
has been used.111–115 Regional differences of OS release compared to 
systemic effects have been investigated in a limited number of thoracic 
surgical studies. The use of desflurane and propofol on alveolar inflammatory 
response from bronchial alveolar lavage (BAL) in the ventilated lung were 
examined after OLV. Patients in the propofol group demonstrated higher 
levels of granulocytes, TNF-alpha and sICAM.116 Similarly, patients 
undergoing OLV demonstrated protective effects of sevoflurane compared to 
propofol, with lowered BAL fluid OS markers, a reduction in postoperative 
complications and ICU stay. This effect may be confounded by a longer length 
of OLV in the propofol group.117 In addition, when localised effects of 
sevoflurane and desflurane were compared, MDA levels from BAL samples 
were higher in patients given desflurane.118 The propensity for inducing higher 
OS by desflurane was also observed in two separate laparoscopic studies, 
where there was greater plasma lipid peroxidation in the desflurane group 
compared with sevoflurane; this effect was more pronounced when nitrous 
oxide (N2O) was used.118,119 Paradoxically, the OS pathway has been 
proposed as one of the ways in which volatile anaesthetic agents may pose a 
risk with long-term occupational exposure.120 Furthermore, OS may be 
involved in neurotoxicity that general anaesthetic (GA) agents can cause in 
developing mammals,121 in particular, repeated N2O exposure has been 
demonstrated to cause OS-related neurotoxicity in rats;122 the neurotoxic 
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effects of repeated exposure of GA agents on the developing human brain is 
currently unknown and a pressing area for further research.123 In summary, 
the heterogeneity of surgical techniques and mechanisms of action of 
anaesthetic agents, in conjunction with variations in patient factors, 
differences in OS biomarker selection and dissimilar clinical endpoints make 
assimilation of what evidence exists extremely challenging. 
Regional anesthesia  
A variety of techniques and pharmacological agents used in the delivery of 
regional anesthesia (RA) may have the potential to further modulate OS.  RA, 
epidurals in particular, can provide superior pain control over opioid-based 
analgesia,124,125 and pain is an important component of the neuro-humoral 
stress responses to surgery. Several small studies have detected an 
alteration in OS as a result of procedural pain in neonates,126–128 the 
association of pain with OS have been demonstrated with simple pain stimuli 
such as a heel prick test. However, there is currently a dearth of data in 
perioperative pain responses and OS.126,128 In adults the majority of work has 
been conducted in patients with chronic pain, where chronic pain syndromes, 
including neuropathic pain have been linked to OS.129,130 Whilst the use of 
rectus sheath blocks in abdominal cancer surgery did not demonstrate a 
change in OS markers,131 epidural anesthesia for laparoscopic pelvic surgery 
did reduce MDA concentrations compared to GA.132 This is clearly another 
area that would benefit from further investigation.  
 
 
The role perioperative oxygen 
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Despite almost universal use perioperatively, there is ferocious debate around 
the ideal concentration of oxygen to use in order to ensure the best clinical 
outcomes.133 The relevance of this is that ROS production is directly linked to 
cellular oxygen partial pressure.134 In fact, both hypoxia and hyperoxia are 
associated with OS; whereas elaborate adaptive reactions are in place to 
cope with hypoxia this is not the case with hyperoxia, directly inflicting 
cell/tissue damage.135 This debate was heightened after publication of the 
controversial World Healthcare Organisation (WHO) recommendations on 
perioperative measures to reduce surgical site infection. This document 
recommends that adult surgical patients undergoing GA with endotracheal 
intubation should receive an FIO2 of 0.8 during and for up to six hours after 
surgery.136 Curiously, this recommendation is supported by virtually no robust 
evidence.137 In contrast, there is substantial evidence demonstrating that high 
oxygen concentrations cause damage to the lung parenchyma.138 A 
retrospective study of intraoperative oxygen usage in more than 73,000 
patients demonstrated a dose-dependent association to respiratory 
complications with higher 30-day mortality in the group receiving high FIO2.139 
Follow-up analyses from one of the many perioperative ‘high versus low’ 
oxygen studies140 has detected a number of concerning signals in patients 
given high (80%) versus low (30%) oxygen concentrations perioperatively; 
these are: i) increased long-term risk of myocardial infarction and other heart 
disease;141 ii) increased long-term mortality;142 and iii) reduced cancer-free 
survival.143  
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What we lack, is a clear understanding of the effects of hyperoxia on cellular 
function during surgery and the thresholds at which harm generally occurs. 
Given the reactive and toxic nature of oxygen, basic first principles would 
suggest that high concentration is only likely to be toxic and studies in the 
critically ill confirm this.144–146 Very few studies have investigated the effects of 
oxygen concentration on OS production during surgery, and its causative links 
with clinical outcomes. 
 
OXIDATIVE STRESS: RELEVANCE TO PERIOPERATIVE OUTCOME 
The impact of preoperative risk factors and intraoperative propagation of OS 
tends to be borne out postoperatively and may manifest as unwanted 
complications and long-term harm. The biological mechanisms underlying the 
syndrome that leads to postoperative demise and multiple organ failure are 
poorly understood. Inflammation may well be a key element, and OS is likely 
to be an important contributor in this setting. Robust biomarkers of 
inflammation are now available to clinicians but those for OS are largely 
experimental. Whilst the synergistic rise in inflammatory markers and OS 
markers are well established, the clinical implications are not so well 
understood.  A small but growing number of clinical studies have 
demonstrated a positive correlation of high perioperative OS with 
postoperative complications, these have been patients undergoing major 
surgery, including liver, lung resections and cardiac surgery.4,34,92,147 The use 
of OS in predicting long-term outcomes may also be feasible; in a study of 21 
cancer patients undergoing lung resection, lower values of diacron reactive 
oxygen metabolites (d-ROMs, a ROS measure of plasma or serum 
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hydroperoxide levels using the Fenton reaction), were associated with a 
significantly higher 3 year survival. 35 
 
PERIOPERATIVE OXIDATIVE STRESS: LOOKING TO THE HORIZON 
In the absence of a perioperative ‘silver bullet’, a multimodal approach to 
pragmatic OS reduction would seem sensible to improve clinical outcomes.  
Perhaps our strongest hand is to engage in public health messaging in order 
to reduce the OS burden in the general population, most of whom will require 
surgery at some point in their life. Smoking cessation, reduction in alcohol 
consumption, increased physical activity, a healthy diet and weight loss in 
obese individuals will improve the health of the nation (Figure 4). Some of 
these interventions can be implemented at the time a patient first knows that 
they will require surgery but will have far less impact in the short lead time 
between diagnosis and operation in a modern healthcare system. The 
population health approach may require anesthesiologists to stray even 
further from the operating room than we may be comfortable with, but if we 
are to improve global surgical outcomes this may ultimately be more effective 
than any drug we have to offer.  
Opportunities are arising in the operating room, where as anesthesiologists 
we will be able to personalise our approach in reducing postoperative 
complications. Through the careful selection of anaesthetic agent, techniques 
and appropriate titration of oxygen level, the term ‘balanced anesthesia’ 
should take a new meaning, moving away from clinicians’ choice based on 
empirical evidence, and towards robust physiological and biochemical 
measures. Select and targeted use of antioxidant compounds, with tailored 
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exercise programmes around the time of surgery may form part of this 
comprehensive package to minimise OS.  
In time, we also need to develop robust methods of surgical risk stratification 
that include elements to identify those at risk from excessive OS. The use of 
an array of targeted biomarkers preoperatively may help to identify those with 
an underlying high OS burden.  It is already known that frailty and pre-frailty 
are associated with raised systemic OS levels,148 the potential for biological 
quantification of important risk factors is a reality. However, in view of the 
complexity of redox biology and multi-compartmental effects of OS, a 
systems-based, full body approach to reflect the redox state of the whole 
person should be what we strive for. Great advances have been made 
through genomic and transcriptomic technology; the study of metabolic 
alterations reflecting downstream changes using an ‘omics style’ panel should 
be adopted to study stress related biology. We should be moving away from 
static and single measures OS outputs, but towards dynamic measures of 
metabolites to characterise the changes during the perioperative period.149 
 
CONCLUSION 
Whilst our understanding of OS is growing, we need to focus attention to how 
it affects the patients we care for. Like inflammation, it is likely to play a major 
role in both healing and harm. As diagnostic biomarker techniques become 
more sophisticated, reliable and accessible, we need to weave this new 
information into more traditional models of care and re-think the way in which 
we select a particular technique or drug for the patient in front of us. Once we 
accept the paradox that oxygen is at the same time enabling life and one of 
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our greatest enemies it will become easier to tackle the epidemic of OS by 
intervening in a more targeted fashion.  
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Fig 1. Mitochondrial and extra-mitochondrial sources of ROS 
The extra mitochondrial sources include peroxisomes, lysosomes, the 
endoplasmic reticulum, the plasma membrane and cytosolic proteins and 
small molecules. 
 
Fig 2. The process of ROS production 
Enzymatic release of superoxide (O2·-) can originate from activities of 
xanthine oxidase (XO), NAPH oxidase (NOX) and respiratory complexes 
within the mitochondrial electron transport chain (ECT). Under some 
conditions, nitric oxide synthase (NOS) can produce both O2·- and nitric oxide 
(NO) to immediately react and form the potent pro-oxidant peroxynitrite 
(ONOO-). Superoxide dismutase (SOD) converts O2·- into hydrogen peroxide 
(H2O2). In addition to inactivation by catalase, H2O2 reacts with glutathione 
peroxidase (GPX) and reduced glutathione (GSH) to form water (H2O) and 
glutathione disulfide (GSSG). Additional enzymes involved in this process 
include peroxiredoxins and thioredoxins. Myeloperoxidase (MPO) produces 
hypochlorite (HOCl) from the reaction of H2O2 with chloride anions (Cl-), the 
Fenton reaction is a non-enzymatic process involving ferrous (Fe2+) ions and 
H2O2 to produce to the highly reactive hydroxl radical (OH.). 
 





Fig 3. A proposed model for the relationship between mitochondrial 
dysfunction and inflammation  
An adapted diagram from Lopez-Armada and colleagues, 2013.3 During the 
initial innate immune response ROS is generated from ROS secreting 
organelles within leukocytes. This leads to activation of downstream redox-
sensitive transcription factors, such as nuclear factor-κB (NF-κB), and 
cytokines, chemokines and iNOS in cells of the surrounding tissue.42 In the 
acute phase, changes to mitochondrial enzyme activities cause increases in 
calcium influx, mitochondrial dysfunction and cell death.150 This in turn results 
in the release of DAMPs, activation of Toll-like receptors (TLRs) and 
nucleotide-binding oligomerizations domain (NOD) like receptors (NLRs), 
propagating on-going inflammation. Mitochondrial DNA (mtDNA) is particularly 
susceptible to oxidative damage due to its close proximity to the site of ROS 
production and the lack of protective histones.151 The accumulation of 
mutations alter the expression of respiratory complex subunits and thus 
OXPHOS efficiency, creating a positive feedback response with further ROS 
release, mitochondrial damage and inflammation.22 Several mechanisms 
have been attributed to mitochondrial ROS-mediated inflammation, including 
activation of tumour necrosis factor receptors (TNFRs) and NOD, Leucine 
Rich Repeat And Pyrin-Domain Containing-3 (NLRP3) inflammasome signals. 
This activation of the inflammasome triggers pro-inflammatory cytokines, 
which are directly driven by mitochondrially mediated ROS and DAMPs, such 
as mtDNA, extracellular ATP and nuclear histones. 






Fig 4. Perioperative redox balance  
The delicate balance between ROS production and removal (affecting redox 
regulation) during surgery, mediated by a variety of factors, many of which are 
modifiable during the perioperative period. 
 
 
